WEREWOLF THERAPEUTICS INC
HOWL · NASDAQ
Updated at 2026-10-15 08:28:24
- Today's High
- $1.02
- Today’s Low
- $0.96
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.99
- Previous Close
- $0.98
- Volume
- 664.07K
- Market Cap
- $47.62M
- P/E Ratio
- --
- EPS
- $-0.73
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 200 TALCOTT AVE, WATERTOWN, MA, UNITED STATES, 02472
- Country
- US
- Listing Date
- 2021-04-30
- Fiscal Year End
- December
- Shares Outstanding
- 48.6M
- CIK
- 0001785530
- Website
- werewolftx.com
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer. The company is headquartered in Cambridge, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$21M
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$10.01M
2026-03-31
$8.56M
2025-12-31
$9.41M
2025-09-30
$15.72M
Net Income
2026-06-30
$3.67M
2026-03-31
-$13.53M
2025-12-31
-$8.38M
2025-09-30
-$16.37M
Net Profit Margin
2026-06-30
17.47%
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$0.08
2026-03-31
$-0.28
2025-12-31
$-0.17
2025-09-30
$-0.36
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
$10.98M
2026-03-31
-$11.76M
2025-12-31
-$6.61M
2025-09-30
-$14.62M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $21M | $0 | $0 | $0 |
| Operating Expenses | $10.01M | $8.56M | $9.41M | $15.72M |
| Net Income | $3.67M | -$13.53M | -$8.38M | -$16.37M |
| Net Profit Margin | 17.47% | -- | -- | -- |
| Earnings Per Share | $0.08 | $-0.28 | $-0.17 | $-0.36 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | $10.98M | -$11.76M | -$6.61M | -$14.62M |
| Effective Tax Rate | -- | -- | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.